Cibc Bancorp Usa Inc. Ptc Therapeutics, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 8,285 shares of PTCT stock, worth $611,598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,285Holding current value
$611,598% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
317Shares Held
80.5MCall Options Held
215KPut Options Held
121K-
Vanguard Group Inc Valley Forge, PA8.29MShares$612 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$574 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$572 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY4.74MShares$350 Million4.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$347 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $5.28B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...